Health officials are launching a fresh study into side effects as data shows number of reported cases of pancreatitis, some ...

The drug works to suppress appetite and has been embraced by celebrities. It's approved by MedSafe but not funded by Pharmac, so users will have to pay. The drug is injected weekly and alongside ...

New figures from the Medicines and Healthcare products Regulatory Agency (MHRA) show the group of drugs that includes ...

Holli Bradish-Lane unveils The GLP-1 Exit Plan, a pioneering book designed to guide individuals safely off weight-loss ...

Exclusive: Julie Bishop lost two-and-a-half stone in eight weeks by taking Mounjaro before she was sent to hospital with pancreatitis and told to stop taking the weight-loss jab ...

Officials are examining whether those affected have a genetic trait that leaves them at greater risk of side-effects from the ...

To address this, researchers tested a new strategy: combining semaglutide (the active ingredient in Ozempic and Wegovy) with an experimental drug called bimagrumab. Bimagrumab is a lab-made antibody ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a new study into GLP-1 medicines after worrying ...

Hundreds of people have reported problems with their pancreas after taking GLP-1 agonists, including ten deaths.

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

FAMILY doctors should ask if patients are secretly using fat jabs, experts say. People with symptoms such as dizziness or gut pain could be suffering side effects from the drugs or have a separate ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...